Last reviewed · How we verify
Clinical Study Evaluating The Role of Vonoprazan Versus Pantoprazole in Patients With Gastroesophageal Reflux Disease
This study aims to investigate the possible efficacy of vonoprazan versus Pantoprazole in patients with gastroesophageal reflux disease.
Details
| Lead sponsor | Tanta University |
|---|---|
| Phase | Phase 4 |
| Status | RECRUITING |
| Enrolment | 44 |
| Start date | 2024-09-18 |
| Completion | 2026-10 |
Conditions
- Gastroesophageal Reflux Disease (GERD)
Interventions
- Vonoprazan 20 mg versus Pantoprazole 40 mg
Primary outcomes
- change in the measured biomarker — Before and after 2 months
Measured biomarkers are serum gastrin hormone and E-Cadherin level
Countries
Egypt